GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Days Inventory

Yumanity Therapeutics (FRA:8IY) Days Inventory : 0.00 (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Yumanity Therapeutics's Average Total Inventories for the three months ended in Sep. 2022 was €0.00 Mil. Yumanity Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2022 was €0.00 Mil.

The historical rank and industry rank for Yumanity Therapeutics's Days Inventory or its related term are showing as below:

FRA:8IY's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 189.655
* Ranked among companies with meaningful Days Inventory only.

Yumanity Therapeutics's Days Inventory stayed the same from Sep. 2021 (0.00) to Sep. 2022 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Yumanity Therapeutics's Inventory-to-Revenue for the three months ended in Sep. 2022 was 0.00.


Yumanity Therapeutics Days Inventory Historical Data

The historical data trend for Yumanity Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Days Inventory Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
Days Inventory
- - -

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Yumanity Therapeutics's Days Inventory

For the Biotechnology subindustry, Yumanity Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yumanity Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yumanity Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Yumanity Therapeutics's Days Inventory falls into.



Yumanity Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Yumanity Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as

Days Inventory (A: Dec. 2021 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2020 ) + Total Inventories (A: Dec. 2021 )) / count ) / Cost of Goods Sold (A: Dec. 2021 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Yumanity Therapeutics's Days Inventory for the quarter that ended in Sep. 2022 is calculated as:

Days Inventory (Q: Sep. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2022 ) + Total Inventories (Q: Sep. 2022 )) / count ) / Cost of Goods Sold (Q: Sep. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yumanity Therapeutics  (FRA:8IY) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Yumanity Therapeutics's Inventory Turnover for the three months ended in Sep. 2022 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Yumanity Therapeutics's Inventory to Revenue for the three months ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Yumanity Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Yumanity Therapeutics (FRA:8IY) Business Description

Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines